Breakout stocks: ITC, Jyothy Labs can rally up to 18%, show charts

ITC and Jyothy Labs have given a breakout above the super trend line resistance on the daily scale; here are the key levels to watch out on these 2 stocks as the trend turned favourable on charts.

stock market, share market, stocks
Breakout stocks: ITC, Jyothy Labs
Rex Cano Mumbai
2 min read Last Updated : Apr 11 2025 | 12:15 PM IST
FMCG major ITC and mid-cap pharma stock Jyothy Labs have given a fresh breakout on the daily scale in the last two trading sessions, thus implying a likely favourable trend in the near-term.  Here's a detailed technical analysis on Today Break Out Stock ITC and Jyothy Labs shares.  ITC  Current Price: ₹ 420  Upside Potential: 9.8%  Support: ₹ 410; ₹ 400; ₹ 395  Resistance: ₹ 431; ₹ 444; ₹ 454  ITC stock has witnessed a breakout on the daily chart in its previous trading session, as the stock closed above its super trend line resistance. The overall bias is now expected to remain favourable as long as the stock holds above ₹ 395. Near support for the stock is visible at ₹ 410 and ₹ 404 levels. CLICK HERE FOR THE CHART  At present, ITC is testing resistance at its 100-Day Simple Moving Average (DSMA) also known as the 100-DMA, which stands at ₹ 421. Break and sustained trade above the stock can see the stock spurt towards the 200-DMA at ₹ 431 levels.  In the short-to-medium term the stock is expected to rally towards ₹ 461 levels, shows the weekly chart. Interim resistance can be anticipated around ₹ 444 and ₹ 454 levels.  ALSO READ: Nestle stock attempts breakout above 200-DMA; is the consolidation over?  Jyothy Labs  Current Price: ₹ 370  Upside Potential: 17.8%  Support: ₹ 352; ₹ 340; ₹ 317  Resistance: ₹ 411; ₹ 426  Jyothy Labs too is seen trading firmly above its super trend line for the second straight day. That apart the stock is also trading above the higher-end of the Bollinger Bands on the daily scale; thus implying a bullish bias for the stock as long as it holds above ₹ 365. CLICK HERE FOR THE CHART  The overall bias for the stock is expected to remain positive as long as the stock trades above ₹ 317 levels. Interim support for the stock is placed at ₹ 352 and ₹ 340 levels.  Key momentum oscillators on the weekly chart, such as the Stochastic Slow and the Moving Average Convergence-Divergence (MACD) indicator have also turned favourable for Jyothy Labs. Chart suggests the stock can potentially rally towards ₹ 435 levels in the near-term. For now, key hurdles for the stock exist at ₹ 411 and ₹ 426 levels. 
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :ITCJyothy LabsFMCG ITCJyothy Laboratoriesstocks technical analysisStocks to buyStocks to buy todayMarket trendsMarket technicalsMarket OutlookStock Recommendationsstock market betsIndian stock markettechnical analysis

First Published: Apr 11 2025 | 12:10 PM IST

Next Story